Follow
Tianling Hou
Title
Cited by
Cited by
Year
Genetically engineered cell-derived nanoparticles for targeted breast cancer immunotherapy
X Shi, Q Cheng, T Hou, M Han, G Smbatyan, JE Lang, AL Epstein, ...
Molecular therapy 28 (2), 536-547, 2020
1632020
Macrophage-based nanotherapeutic strategies in ulcerative colitis
J Zhang, Y Zhao, T Hou, H Zeng, D Kalambhe, B Wang, X Shen, Y Huang
Journal of controlled release 320, 363-380, 2020
912020
Potential therapeutic effects of Cordyceps cicadae and Paecilomyces cicadae on adenine-induced chronic renal failure in rats and their phytochemical analysis
L Li, T Zhang, C Li, L Xie, N Li, T Hou, Y Wang, B Wang
Drug Design, Development and Therapy, 103-117, 2019
402019
Integrated multi-class classification and prediction of GPCR allosteric modulators by machine learning intelligence
T Hou, Y Bian, T McGuire, XQ Xie
Biomolecules 11 (6), 870, 2021
192021
Expanding the toolbox of exosome-based modulators of cell functions
Q Cheng, Z Dai, X Shi, X Duan, Y Wang, T Hou, Y Zhang
Biomaterials 277, 121129, 2021
162021
Binding characterization of GPCRs-modulator by molecular complex characterizing system (MCCS)
Z Feng, T Liang, S Wang, M Chen, T Hou, J Zhao, H Chen, Y Zhou, ...
ACS chemical neuroscience 11 (20), 3333-3345, 2020
82020
Site-specific antibody-drug conjugates with variable drug-to-antibody-ratios for AML therapy
Z Dai, XN Zhang, Q Cheng, F Fei, T Hou, J Li, A Abdolvahabi, J Watanabe, ...
Journal of Controlled Release 336, 433-442, 2021
42021
Comparison of Pinoresinol and its Diglucoside on their ADME Properties and Vasorelaxant Effects on Phenylephrine-Induced Model
Y Pu, Y Cai, Q Zhang, T Hou, T Zhang, T Zhang, B Wang
Frontiers in pharmacology 12, 695530, 2021
42021
聚维酮联用轻质碳酸钙用于槲皮素固体分散体的制备及评价
侯天凌, 张琦, 刘丽花, 郭伊霖, 王冰
中国实验方剂学杂志 23 (10), 17-21, 2017
12017
黄皮叶提取物滴丸的制备及初步稳定性评价
刘丽花, 张琦, 侯天凌, 于江珲, 熊静, 俞晓鸥, 王冰
数理医药学杂志 29 (12), 1809-1812, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–10